Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention
Clinical trial NCT02508116 · COMPLETED
Trial details
- NCT number
- NCT02508116
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-05-01
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.